169
Views
0
CrossRef citations to date
0
Altmetric
Article

Contribution of Fatigue to Cognitive Dysfunction in Childhood Acute Lymphoblastic Leukemia Survivors

, , , , , , , , & show all
Pages 554-567 | Received 22 Dec 2022, Accepted 06 May 2023, Published online: 20 Jul 2023

References

  • Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol. 2012;30(14):1663–1669. doi:10.1200/JCO.2011.37.8018.
  • Krull KR, Cheung YT, Liu W, et al. Chemotherapy pharmacodynamics and neuroimaging and neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2016;34(22):2644–2653. doi:10.1200/JCO.2015.65.4574.
  • Mavrea K, Efthymiou V, Katsibardi K, et al. Cognitive function of children and adolescent survivors of acute lymphoblastic leukemia: a meta‑analysis. Oncol Lett. 2021;21(4):262. doi:10.3892/ol.2021.12523.
  • Sorensen GV, Winther JF, de Fine Licht S, et al. Long-term risk of hospitalization among five-year survivors of childhood leukemia in the Nordic countries. J Natl Cancer Inst. 2019;111(9):943–951.
  • Reddick WE, Taghipour DJ, Glass JO, et al. Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers. Pediatr Blood Cancer. 2014;61(6):1074–1079. doi:10.1002/pbc.24947.
  • Van der Plas E, Spencer Noakes TL, Butcher DT, et al. Quantitative MRI outcomes in child and adolescent leukemia survivors: evidence for global alterations in gray and white matter. Neuroimage Clin. 2020;28:102428. doi:10.1016/j.nicl.2020.102428.
  • Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–2381. doi:10.1001/jama.2013.6296.
  • Krull KR, Brinkman TM, Li C, et al. Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study. J Clin Oncol. 2013;31(35):4407–4415. doi:10.1200/JCO.2012.48.2315.
  • Hearps S, Seal M, Anderson V, et al. The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: a systematic review. Pediatr Blood Cancer. 2017;64(2):225–233. doi:10.1002/pbc.26188.
  • Reddick WE, Conklin HM. Impact of acute lymphoblastic leukemia therapy on attention and working memory in children. Expert Rev Hematol. 2010;3(6):655–659. doi:10.1586/ehm.10.65.
  • Van der Plas E, Nieman BJ, Butcher DT, et al. Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: focus on methotrexate. J Can Acad Child Adolesc Psychiatry. 2015;24(1):25–32.
  • Edelmann MN, Ogg RJ, Scoggins MA, et al. Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: a report from the SJLIFE cohort. Pediatr Blood Cancer. 2013;60(11):1778–1784. doi:10.1002/pbc.24644.
  • Hill DE, Ciesielski KT, Hart BL, Jung RE. MRI morphometric and neuropsychological correlates of long-term memory in survivors of childhood leukemia. Pediatr Blood Cancer. 2004;42(7):611–617. doi:10.1002/pbc.20004.
  • Iyer NS, Balsamo LM, Bracken MB, Kadan-Lottick NS. Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis. Blood. 2015;126(3):346–353. doi:10.1182/blood-2015-02-627414.
  • Anestin AS, Lippe S, Robaey P, et al. Psychological risk in long-term survivors of childhood acute lymphoblastic leukemia and its association with functional health status: a PETALE cohort study. Pediatr Blood Cancer. 2018;65(11):e27356. doi:10.1002/pbc.27356.
  • Gordijn MS, van Litsenburg RR, Gemke RJ, et al. Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(3):479–485. doi:10.1002/pbc.24261.
  • Olson K, Saligan LN, Piper BF. Cancer-related fatigue. In: Olver I, ed. The MASCC Textbook of Cancer Supportive Care and Survivorship. Cham: Springer International Publishing; 2018:37–52.
  • Hamre H, Zeller B, Kanellopoulos A, et al. High prevalence of chronic fatigue in adult long-term survivors of acute lymphoblastic leukemia and lymphoma during childhood and adolescence. J Adolesc Young Adult Oncol. 2013;2(1):2–9. doi:10.1089/jayao.2012.0015.
  • Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L. Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol. 2005;23(24):5501–5510. doi:10.1200/JCO.2005.03.210.
  • Mulrooney DA, Ness KK, Neglia JP, et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep. 2008;31(2):271–281. doi:10.1093/sleep/31.2.271.
  • Cheung YT, Brinkman TM, Mulrooney DA, et al. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia. Cancer. 2017;123(17):3410–3419. doi:10.1002/cncr.30742.
  • Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–2715. doi:10.1001/jama.297.24.2705.
  • Lowe CJ, Safati A, Hall PA. The neurocognitive consequences of sleep restriction: a meta-analytic review. Neurosci Biobehav Rev. 2017;80:586–604. doi:10.1016/j.neubiorev.2017.07.010.
  • Clanton NR, Klosky JL, Li C, et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer. Cancer. 2011;117(11):2559–2568. doi:10.1002/cncr.25797.
  • Boulet-Craig A, Robaey P, Laniel J, et al. DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: a PETALE study. Pediatr Blood Cancer. 2018;65(9):e27259. doi:10.1002/pbc.27259.
  • Walter LM, Nixon GM, Davey MJ, Downie PA, Horne RSC. Sleep and fatigue in pediatric oncology: a review of the literature. Sleep Med Rev. 2015;24:71–82. doi:10.1016/j.smrv.2015.01.001.
  • Askins MA, Moore BD. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol. 2008;23(10):1160–1171. doi:10.1177/0883073808321065.
  • Marcoux S, Drouin S, Laverdiere C, et al. The PETALE study: late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Pediatr Blood Cancer. 2017;64(6):e26361. doi:10.1002/pbc.26361.
  • Silverman LB, Stevenson KE, O'Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000). Leukemia. 2010;24(2):320–334. doi:10.1038/leu.2009.253.
  • Wechsler D. Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: The Psychological Corporation; 2003.
  • Wechsler D. Wechsler Adult Intelligence Scale. 4th ed. San Antonio, TX: NCS Pearson; 2008.
  • Delis DC, Kaplan E, Kramer JH. Delis–Kaplan Executive Function System (D-KEFS). Psychological Corporation, San Antonio, TX, USA; 2001.
  • Kløve H. Grooved Pegboard. Lafayette, IN: Lafayette Instruments; 1963.
  • Krull KR, Okcu MF, Potter B, et al. Screening for neurocognitive impairment in pediatric cancer long-term survivors. J Clin Oncol. 2008;26(25):4138–4143. doi:10.1200/JCO.2008.16.8864.
  • Guilmette TJ, Sweet JJ, Hebben N, et al. American Academy of Clinical Neuropsychology consensus conference statement on uniform labeling of performance test scores. Clin Neuropsychol. 2020;34(3):437–453. doi:10.1080/13854046.2020.1722244.
  • Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL™ in pediatric cancer: reliability and validity of the pediatric quality of life inventory™ generic core scales, multidimensional fatigue scale, and cancer module. Cancer. 2002;94(7):2090–2106. doi:10.1002/cncr.10428.
  • Cohen J. A power primer. Psychol Bull. 1992;112(1):155–159. doi:10.1037//0033-2909.112.1.155.
  • Okado Y, Rowley C, Schepers SA, Long AM, Phipps S. Profiles of adjustment in pediatric cancer survivors and their prediction by earlier psychosocial factors. J Pediatr Psychol. 2018;43(9):1047–1058. doi:10.1093/jpepsy/jsy037.
  • Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 2018;36(21):2181–2189. doi:10.1200/JCO.2017.76.4696.
  • Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961–968. doi:10.1001/jamaoncol.2016.6914.
  • Saligan LN, Olson K, Filler K, et al. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461–2478. doi:10.1007/s00520-015-2763-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.